Isopsoralen alleviates osteoarthritis by modulating the MAPK/NF-κB signaling pathway and regulating the structure of gut microbiota.

Researchers have investigated isopsoralen, a natural compound extracted from Psoralea corylifolia L. (a traditional Chinese herb), for treating osteoarthritis (OA). This herb has been documented in traditional Chinese medicine texts since the Ming Dynasty for relieving knee joint pain and strengthening bones. The study examined how isopsoralen works in mice with surgically-induced osteoarthritis, similar to human degenerative joint disease.

The researchers found that isopsoralen worked through multiple mechanisms. It reduced inflammation by blocking specific cellular pathways (MAPK/NF-κB signaling) that drive joint damage. Importantly, the compound also altered the composition of gut bacteria and increased beneficial short-chain fatty acids in the intestines. When researchers transplanted gut bacteria from treated mice into untreated ones, the recipients also showed improvement, confirming that changes in gut microbiota were essential to the therapeutic effect.

Treatment with isopsoralen led to measurable improvements: reduced cartilage breakdown, decreased bone abnormalities beneath the cartilage, and less joint inflammation. Safety testing showed no liver or kidney toxicity. The findings suggest that osteoarthritis is not just a local joint problem but involves systemic factors including gut health.

For patients considering integrative approaches to osteoarthritis, this research supports the traditional use of Psoralea corylifolia in Chinese herbal medicine. The gut-joint connection identified in this study aligns with holistic treatment principles common in Traditional Chinese Medicine, where practitioners often address digestive health when treating musculoskeletal conditions. If you're interested in exploring herbal medicine or acupuncture for osteoarthritis management, consult with a qualified, licensed acupuncturist or herbalist trained in Traditional Chinese Medicine.

This study investigated isopsoralen (ISO), a bioactive compound from Psoralea corylifolia L., using a destabilization of medial meniscus (DMM)-induced osteoarthritis mouse model. Network pharmacology predicted multi-target effects, which were validated through behavioral assessment, micro-CT imaging, histological analysis, Western blot, and PCR. ISO treatment downregulated MAPK/NF-κB inflammatory pathways, reduced subchondral bone abnormalities, and attenuated cartilage degeneration. Significantly, 16S rDNA sequencing revealed that ISO modulated gut microbiota composition and increased short-chain fatty acid production. Fecal microbiota transplantation (FMT) experiments demonstrated that gut microbiota restructuring was essential for therapeutic efficacy—pseudo germ-free mice showed diminished ISO response, while FMT from ISO-treated donors conferred protection. No hepatorenal toxicity was observed in safety assessments. Clinical relevance: This research validates traditional applications of Psoralea corylifolia for joint disorders and suggests that herbal interventions for OA may work through gut-joint axis modulation, supporting integrative treatment approaches combining herbal medicine with other TCM modalities for osteoarthritis management.